nodes	percent_of_prediction	percent_of_DWPC	metapath
Estradiol valerate/Dienogest—CYP3A4—Cytarabine—lymphatic system cancer	0.241	0.318	CbGbCtD
Estradiol valerate/Dienogest—CYP3A4—Teniposide—lymphatic system cancer	0.237	0.313	CbGbCtD
Estradiol valerate/Dienogest—CYP3A4—Mitoxantrone—lymphatic system cancer	0.166	0.219	CbGbCtD
Estradiol valerate/Dienogest—CYP3A4—Vincristine—lymphatic system cancer	0.114	0.151	CbGbCtD
Estradiol valerate/Dienogest—Mood alteration NOS—Methotrexate—lymphatic system cancer	0.0076	0.0315	CcSEcCtD
Estradiol valerate/Dienogest—Thrombophlebitis—Mechlorethamine—lymphatic system cancer	0.00666	0.0276	CcSEcCtD
Estradiol valerate/Dienogest—Hypocalcaemia—Fludarabine—lymphatic system cancer	0.00562	0.0233	CcSEcCtD
Estradiol valerate/Dienogest—Abdominal cramps—Vincristine—lymphatic system cancer	0.00465	0.0193	CcSEcCtD
Estradiol valerate/Dienogest—Depression—Mechlorethamine—lymphatic system cancer	0.00443	0.0184	CcSEcCtD
Estradiol valerate/Dienogest—Tenderness—Bleomycin—lymphatic system cancer	0.00432	0.0179	CcSEcCtD
Estradiol valerate/Dienogest—Visual disturbance—Fludarabine—lymphatic system cancer	0.00394	0.0163	CcSEcCtD
Estradiol valerate/Dienogest—Cerebrovascular accident—Fludarabine—lymphatic system cancer	0.00381	0.0158	CcSEcCtD
Estradiol valerate/Dienogest—Erythema multiforme—Mechlorethamine—lymphatic system cancer	0.00377	0.0156	CcSEcCtD
Estradiol valerate/Dienogest—Dementia—Methotrexate—lymphatic system cancer	0.00372	0.0154	CcSEcCtD
Estradiol valerate/Dienogest—Hypocalcaemia—Mitoxantrone—lymphatic system cancer	0.00334	0.0139	CcSEcCtD
Estradiol valerate/Dienogest—Pulmonary embolism—Carmustine—lymphatic system cancer	0.00329	0.0136	CcSEcCtD
Estradiol valerate/Dienogest—Acute coronary syndrome—Fludarabine—lymphatic system cancer	0.00284	0.0118	CcSEcCtD
Estradiol valerate/Dienogest—Anaphylactic shock—Mechlorethamine—lymphatic system cancer	0.00283	0.0117	CcSEcCtD
Estradiol valerate/Dienogest—Myocardial infarction—Fludarabine—lymphatic system cancer	0.00282	0.0117	CcSEcCtD
Estradiol valerate/Dienogest—Cerebrovascular accident—Bleomycin—lymphatic system cancer	0.00279	0.0116	CcSEcCtD
Estradiol valerate/Dienogest—Thrombophlebitis—Carmustine—lymphatic system cancer	0.00276	0.0114	CcSEcCtD
Estradiol valerate/Dienogest—Vaginal discharge—Methotrexate—lymphatic system cancer	0.00251	0.0104	CcSEcCtD
Estradiol valerate/Dienogest—Visual impairment—Fludarabine—lymphatic system cancer	0.00249	0.0103	CcSEcCtD
Estradiol valerate/Dienogest—Erythema multiforme—Fludarabine—lymphatic system cancer	0.00244	0.0101	CcSEcCtD
Estradiol valerate/Dienogest—Malnutrition—Fludarabine—lymphatic system cancer	0.00225	0.00932	CcSEcCtD
Estradiol valerate/Dienogest—Weight decreased—Bleomycin—lymphatic system cancer	0.00214	0.00887	CcSEcCtD
Estradiol valerate/Dienogest—Oedema—Teniposide—lymphatic system cancer	0.00209	0.00865	CcSEcCtD
Estradiol valerate/Dienogest—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.00209	0.00865	CcSEcCtD
Estradiol valerate/Dienogest—Acute coronary syndrome—Bleomycin—lymphatic system cancer	0.00208	0.00862	CcSEcCtD
Estradiol valerate/Dienogest—Myocardial infarction—Bleomycin—lymphatic system cancer	0.00207	0.00857	CcSEcCtD
Estradiol valerate/Dienogest—Pruritus—Mechlorethamine—lymphatic system cancer	0.002	0.0083	CcSEcCtD
Estradiol valerate/Dienogest—Depression—Carmustine—lymphatic system cancer	0.00184	0.00761	CcSEcCtD
Estradiol valerate/Dienogest—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.00183	0.00761	CcSEcCtD
Estradiol valerate/Dienogest—Oedema—Fludarabine—lymphatic system cancer	0.00183	0.00761	CcSEcCtD
Estradiol valerate/Dienogest—Vomiting—Mechlorethamine—lymphatic system cancer	0.0018	0.00746	CcSEcCtD
Estradiol valerate/Dienogest—Nervous system disorder—Fludarabine—lymphatic system cancer	0.0018	0.00746	CcSEcCtD
Estradiol valerate/Dienogest—Rash—Mechlorethamine—lymphatic system cancer	0.00179	0.0074	CcSEcCtD
Estradiol valerate/Dienogest—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00178	0.00739	CcSEcCtD
Estradiol valerate/Dienogest—Weight decreased—Vincristine—lymphatic system cancer	0.00178	0.00739	CcSEcCtD
Estradiol valerate/Dienogest—Depression—Vincristine—lymphatic system cancer	0.00175	0.00726	CcSEcCtD
Estradiol valerate/Dienogest—Weight increased—Mitoxantrone—lymphatic system cancer	0.00175	0.00724	CcSEcCtD
Estradiol valerate/Dienogest—Weight decreased—Mitoxantrone—lymphatic system cancer	0.00174	0.0072	CcSEcCtD
Estradiol valerate/Dienogest—Acute coronary syndrome—Vincristine—lymphatic system cancer	0.00173	0.00718	CcSEcCtD
Estradiol valerate/Dienogest—Myocardial infarction—Vincristine—lymphatic system cancer	0.00172	0.00714	CcSEcCtD
Estradiol valerate/Dienogest—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00171	0.00708	CcSEcCtD
Estradiol valerate/Dienogest—Acute coronary syndrome—Mitoxantrone—lymphatic system cancer	0.00169	0.00699	CcSEcCtD
Estradiol valerate/Dienogest—Nausea—Mechlorethamine—lymphatic system cancer	0.00168	0.00697	CcSEcCtD
Estradiol valerate/Dienogest—Myocardial infarction—Mitoxantrone—lymphatic system cancer	0.00168	0.00695	CcSEcCtD
Estradiol valerate/Dienogest—Urticaria—Teniposide—lymphatic system cancer	0.00166	0.00687	CcSEcCtD
Estradiol valerate/Dienogest—Abdominal pain—Teniposide—lymphatic system cancer	0.00165	0.00684	CcSEcCtD
Estradiol valerate/Dienogest—Connective tissue disorder—Carmustine—lymphatic system cancer	0.00162	0.00673	CcSEcCtD
Estradiol valerate/Dienogest—Dyspepsia—Fludarabine—lymphatic system cancer	0.00162	0.00669	CcSEcCtD
Estradiol valerate/Dienogest—Visual impairment—Carmustine—lymphatic system cancer	0.00159	0.0066	CcSEcCtD
Estradiol valerate/Dienogest—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.00158	0.00657	CcSEcCtD
Estradiol valerate/Dienogest—Fatigue—Fludarabine—lymphatic system cancer	0.00158	0.00656	CcSEcCtD
Estradiol valerate/Dienogest—Pain—Fludarabine—lymphatic system cancer	0.00157	0.0065	CcSEcCtD
Estradiol valerate/Dienogest—Connective tissue disorder—Vincristine—lymphatic system cancer	0.00155	0.00643	CcSEcCtD
Estradiol valerate/Dienogest—Eye disorder—Carmustine—lymphatic system cancer	0.00154	0.0064	CcSEcCtD
Estradiol valerate/Dienogest—Hypersensitivity—Teniposide—lymphatic system cancer	0.00154	0.00638	CcSEcCtD
Estradiol valerate/Dienogest—Vaginal inflammation—Methotrexate—lymphatic system cancer	0.00152	0.00632	CcSEcCtD
Estradiol valerate/Dienogest—Pulmonary embolism—Methotrexate—lymphatic system cancer	0.00152	0.00632	CcSEcCtD
Estradiol valerate/Dienogest—Asthenia—Teniposide—lymphatic system cancer	0.0015	0.00621	CcSEcCtD
Estradiol valerate/Dienogest—Pruritus—Teniposide—lymphatic system cancer	0.00148	0.00612	CcSEcCtD
Estradiol valerate/Dienogest—Cardiac disorder—Vincristine—lymphatic system cancer	0.00146	0.00607	CcSEcCtD
Estradiol valerate/Dienogest—Mental disorder—Carmustine—lymphatic system cancer	0.00145	0.006	CcSEcCtD
Estradiol valerate/Dienogest—Vaginal infection—Methotrexate—lymphatic system cancer	0.00144	0.00597	CcSEcCtD
Estradiol valerate/Dienogest—Malnutrition—Carmustine—lymphatic system cancer	0.00144	0.00596	CcSEcCtD
Estradiol valerate/Dienogest—Mental disorder—Vincristine—lymphatic system cancer	0.00138	0.00573	CcSEcCtD
Estradiol valerate/Dienogest—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00135	0.0056	CcSEcCtD
Estradiol valerate/Dienogest—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.00135	0.00558	CcSEcCtD
Estradiol valerate/Dienogest—Oedema—Bleomycin—lymphatic system cancer	0.00135	0.00558	CcSEcCtD
Estradiol valerate/Dienogest—Vomiting—Teniposide—lymphatic system cancer	0.00133	0.0055	CcSEcCtD
Estradiol valerate/Dienogest—Asthenia—Fludarabine—lymphatic system cancer	0.00132	0.00546	CcSEcCtD
Estradiol valerate/Dienogest—Rash—Teniposide—lymphatic system cancer	0.00132	0.00546	CcSEcCtD
Estradiol valerate/Dienogest—Dermatitis—Teniposide—lymphatic system cancer	0.00132	0.00545	CcSEcCtD
Estradiol valerate/Dienogest—Headache—Teniposide—lymphatic system cancer	0.00131	0.00542	CcSEcCtD
Estradiol valerate/Dienogest—Pruritus—Fludarabine—lymphatic system cancer	0.0013	0.00538	CcSEcCtD
Estradiol valerate/Dienogest—Thrombophlebitis—Methotrexate—lymphatic system cancer	0.00128	0.0053	CcSEcCtD
Estradiol valerate/Dienogest—Nausea—Teniposide—lymphatic system cancer	0.00124	0.00514	CcSEcCtD
Estradiol valerate/Dienogest—Anxiety—Carmustine—lymphatic system cancer	0.00122	0.00506	CcSEcCtD
Estradiol valerate/Dienogest—Oedema—Carmustine—lymphatic system cancer	0.00117	0.00487	CcSEcCtD
Estradiol valerate/Dienogest—Visual disturbance—Methotrexate—lymphatic system cancer	0.00117	0.00484	CcSEcCtD
Estradiol valerate/Dienogest—Vomiting—Fludarabine—lymphatic system cancer	0.00117	0.00484	CcSEcCtD
Estradiol valerate/Dienogest—Rash—Fludarabine—lymphatic system cancer	0.00116	0.0048	CcSEcCtD
Estradiol valerate/Dienogest—Dermatitis—Fludarabine—lymphatic system cancer	0.00116	0.00479	CcSEcCtD
Estradiol valerate/Dienogest—Pain—Bleomycin—lymphatic system cancer	0.00115	0.00477	CcSEcCtD
Estradiol valerate/Dienogest—Headache—Fludarabine—lymphatic system cancer	0.00115	0.00476	CcSEcCtD
Estradiol valerate/Dienogest—Anxiety—Mitoxantrone—lymphatic system cancer	0.00113	0.0047	CcSEcCtD
Estradiol valerate/Dienogest—Cerebrovascular accident—Methotrexate—lymphatic system cancer	0.00113	0.00468	CcSEcCtD
Estradiol valerate/Dienogest—Anaphylactic shock—Vincristine—lymphatic system cancer	0.00112	0.00465	CcSEcCtD
Estradiol valerate/Dienogest—Oedema—Vincristine—lymphatic system cancer	0.00112	0.00465	CcSEcCtD
Estradiol valerate/Dienogest—Nervous system disorder—Vincristine—lymphatic system cancer	0.0011	0.00456	CcSEcCtD
Estradiol valerate/Dienogest—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.00109	0.00453	CcSEcCtD
Estradiol valerate/Dienogest—Oedema—Mitoxantrone—lymphatic system cancer	0.00109	0.00453	CcSEcCtD
Estradiol valerate/Dienogest—Nausea—Fludarabine—lymphatic system cancer	0.00109	0.00452	CcSEcCtD
Estradiol valerate/Dienogest—Urticaria—Bleomycin—lymphatic system cancer	0.00107	0.00443	CcSEcCtD
Estradiol valerate/Dienogest—Irritability—Methotrexate—lymphatic system cancer	0.00106	0.00438	CcSEcCtD
Estradiol valerate/Dienogest—Mood swings—Methotrexate—lymphatic system cancer	0.00105	0.00435	CcSEcCtD
Estradiol valerate/Dienogest—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00101	0.0042	CcSEcCtD
Estradiol valerate/Dienogest—Pain—Carmustine—lymphatic system cancer	0.001	0.00416	CcSEcCtD
Estradiol valerate/Dienogest—Breast disorder—Methotrexate—lymphatic system cancer	0.001	0.00415	CcSEcCtD
Estradiol valerate/Dienogest—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000991	0.00411	CcSEcCtD
Estradiol valerate/Dienogest—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000968	0.00401	CcSEcCtD
Estradiol valerate/Dienogest—Fatigue—Vincristine—lymphatic system cancer	0.000966	0.00401	CcSEcCtD
Estradiol valerate/Dienogest—Asthenia—Bleomycin—lymphatic system cancer	0.000965	0.004	CcSEcCtD
Estradiol valerate/Dienogest—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000961	0.00398	CcSEcCtD
Estradiol valerate/Dienogest—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00096	0.00398	CcSEcCtD
Estradiol valerate/Dienogest—Pain—Vincristine—lymphatic system cancer	0.000959	0.00397	CcSEcCtD
Estradiol valerate/Dienogest—Asthma—Methotrexate—lymphatic system cancer	0.000956	0.00396	CcSEcCtD
Estradiol valerate/Dienogest—Pruritus—Bleomycin—lymphatic system cancer	0.000952	0.00395	CcSEcCtD
Estradiol valerate/Dienogest—Fatigue—Mitoxantrone—lymphatic system cancer	0.000941	0.0039	CcSEcCtD
Estradiol valerate/Dienogest—Pancreatitis—Methotrexate—lymphatic system cancer	0.000938	0.00389	CcSEcCtD
Estradiol valerate/Dienogest—Pain—Mitoxantrone—lymphatic system cancer	0.000934	0.00387	CcSEcCtD
Estradiol valerate/Dienogest—Abdominal pain—Carmustine—lymphatic system cancer	0.000928	0.00385	CcSEcCtD
Estradiol valerate/Dienogest—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000917	0.0038	CcSEcCtD
Estradiol valerate/Dienogest—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000893	0.0037	CcSEcCtD
Estradiol valerate/Dienogest—Abdominal pain—Vincristine—lymphatic system cancer	0.000886	0.00367	CcSEcCtD
Estradiol valerate/Dienogest—Urticaria—Mitoxantrone—lymphatic system cancer	0.000867	0.00359	CcSEcCtD
Estradiol valerate/Dienogest—Hypersensitivity—Carmustine—lymphatic system cancer	0.000865	0.00359	CcSEcCtD
Estradiol valerate/Dienogest—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000863	0.00358	CcSEcCtD
Estradiol valerate/Dienogest—Vomiting—Bleomycin—lymphatic system cancer	0.000855	0.00355	CcSEcCtD
Estradiol valerate/Dienogest—Depression—Methotrexate—lymphatic system cancer	0.00085	0.00352	CcSEcCtD
Estradiol valerate/Dienogest—Rash—Bleomycin—lymphatic system cancer	0.000848	0.00352	CcSEcCtD
Estradiol valerate/Dienogest—Dermatitis—Bleomycin—lymphatic system cancer	0.000847	0.00351	CcSEcCtD
Estradiol valerate/Dienogest—Asthenia—Carmustine—lymphatic system cancer	0.000842	0.00349	CcSEcCtD
Estradiol valerate/Dienogest—Hypersensitivity—Vincristine—lymphatic system cancer	0.000826	0.00342	CcSEcCtD
Estradiol valerate/Dienogest—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000804	0.00333	CcSEcCtD
Estradiol valerate/Dienogest—Asthenia—Vincristine—lymphatic system cancer	0.000804	0.00333	CcSEcCtD
Estradiol valerate/Dienogest—Nausea—Bleomycin—lymphatic system cancer	0.000799	0.00331	CcSEcCtD
Estradiol valerate/Dienogest—Asthenia—Mitoxantrone—lymphatic system cancer	0.000783	0.00325	CcSEcCtD
Estradiol valerate/Dienogest—Dizziness—Carmustine—lymphatic system cancer	0.000777	0.00322	CcSEcCtD
Estradiol valerate/Dienogest—Vomiting—Carmustine—lymphatic system cancer	0.000747	0.00309	CcSEcCtD
Estradiol valerate/Dienogest—Dizziness—Vincristine—lymphatic system cancer	0.000741	0.00307	CcSEcCtD
Estradiol valerate/Dienogest—Rash—Carmustine—lymphatic system cancer	0.00074	0.00307	CcSEcCtD
Estradiol valerate/Dienogest—Dermatitis—Carmustine—lymphatic system cancer	0.00074	0.00307	CcSEcCtD
Estradiol valerate/Dienogest—Visual impairment—Methotrexate—lymphatic system cancer	0.000738	0.00306	CcSEcCtD
Estradiol valerate/Dienogest—Headache—Carmustine—lymphatic system cancer	0.000736	0.00305	CcSEcCtD
Estradiol valerate/Dienogest—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000724	0.003	CcSEcCtD
Estradiol valerate/Dienogest—Eye disorder—Methotrexate—lymphatic system cancer	0.000715	0.00297	CcSEcCtD
Estradiol valerate/Dienogest—Vomiting—Vincristine—lymphatic system cancer	0.000713	0.00295	CcSEcCtD
Estradiol valerate/Dienogest—Cardiac disorder—Methotrexate—lymphatic system cancer	0.000711	0.00295	CcSEcCtD
Estradiol valerate/Dienogest—Rash—Vincristine—lymphatic system cancer	0.000707	0.00293	CcSEcCtD
Estradiol valerate/Dienogest—Dermatitis—Vincristine—lymphatic system cancer	0.000706	0.00293	CcSEcCtD
Estradiol valerate/Dienogest—Headache—Vincristine—lymphatic system cancer	0.000702	0.00291	CcSEcCtD
Estradiol valerate/Dienogest—Nausea—Carmustine—lymphatic system cancer	0.000697	0.00289	CcSEcCtD
Estradiol valerate/Dienogest—Vomiting—Mitoxantrone—lymphatic system cancer	0.000694	0.00288	CcSEcCtD
Estradiol valerate/Dienogest—Immune system disorder—Methotrexate—lymphatic system cancer	0.000691	0.00287	CcSEcCtD
Estradiol valerate/Dienogest—Rash—Mitoxantrone—lymphatic system cancer	0.000688	0.00285	CcSEcCtD
Estradiol valerate/Dienogest—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000688	0.00285	CcSEcCtD
Estradiol valerate/Dienogest—Headache—Mitoxantrone—lymphatic system cancer	0.000684	0.00283	CcSEcCtD
Estradiol valerate/Dienogest—Mental disorder—Methotrexate—lymphatic system cancer	0.000671	0.00278	CcSEcCtD
Estradiol valerate/Dienogest—Malnutrition—Methotrexate—lymphatic system cancer	0.000666	0.00276	CcSEcCtD
Estradiol valerate/Dienogest—Nausea—Vincristine—lymphatic system cancer	0.000666	0.00276	CcSEcCtD
Estradiol valerate/Dienogest—Nausea—Mitoxantrone—lymphatic system cancer	0.000648	0.00269	CcSEcCtD
Estradiol valerate/Dienogest—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000544	0.00225	CcSEcCtD
Estradiol valerate/Dienogest—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000533	0.00221	CcSEcCtD
Estradiol valerate/Dienogest—Dyspepsia—Methotrexate—lymphatic system cancer	0.000479	0.00198	CcSEcCtD
Estradiol valerate/Dienogest—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.00047	0.00195	CcSEcCtD
Estradiol valerate/Dienogest—Fatigue—Methotrexate—lymphatic system cancer	0.000469	0.00194	CcSEcCtD
Estradiol valerate/Dienogest—Pain—Methotrexate—lymphatic system cancer	0.000465	0.00193	CcSEcCtD
Estradiol valerate/Dienogest—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000445	0.00184	CcSEcCtD
Estradiol valerate/Dienogest—Urticaria—Methotrexate—lymphatic system cancer	0.000432	0.00179	CcSEcCtD
Estradiol valerate/Dienogest—Abdominal pain—Methotrexate—lymphatic system cancer	0.00043	0.00178	CcSEcCtD
Estradiol valerate/Dienogest—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000401	0.00166	CcSEcCtD
Estradiol valerate/Dienogest—Asthenia—Methotrexate—lymphatic system cancer	0.00039	0.00162	CcSEcCtD
Estradiol valerate/Dienogest—Pruritus—Methotrexate—lymphatic system cancer	0.000385	0.0016	CcSEcCtD
Estradiol valerate/Dienogest—Dizziness—Methotrexate—lymphatic system cancer	0.00036	0.00149	CcSEcCtD
Estradiol valerate/Dienogest—Vomiting—Methotrexate—lymphatic system cancer	0.000346	0.00143	CcSEcCtD
Estradiol valerate/Dienogest—Rash—Methotrexate—lymphatic system cancer	0.000343	0.00142	CcSEcCtD
Estradiol valerate/Dienogest—Dermatitis—Methotrexate—lymphatic system cancer	0.000343	0.00142	CcSEcCtD
Estradiol valerate/Dienogest—Headache—Methotrexate—lymphatic system cancer	0.000341	0.00141	CcSEcCtD
Estradiol valerate/Dienogest—Nausea—Methotrexate—lymphatic system cancer	0.000323	0.00134	CcSEcCtD
